Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01505049 · ClinicalTrials.gov registry record
Immune Memory After Papillomavirus Vaccination
A clinical trial of Healthy Volunteers, sponsored by Emory University.
- Completed
- Registry status
- 203
- Enrollment target
- 1
- Study location
NCT01505049 is a study of Healthy Volunteers that has completed, run by Emory University. The registered enrollment target is 203 participants, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01505049, a study of Healthy Volunteers, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 203 participants
- Enrollment target
- 1
- Study location
Study Summary
Vaccines for human papillomavirus (HPV) have been available in the United States since 2006. Early studies have shown a high rate of effectiveness of these vaccines, however it is not known how long this protection will last. The IMAP study will look at various parts of the immune system and potential markers for long lived immune responses to this vaccine.
Conditions Studied
Interventions
- DRUG quadrivalent HPV vaccine
Study Locations (1)
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2012-01 |
| Est. Completion | 2015-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01505049
The ClinicalTrials.gov registry entry for NCT01505049 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (58% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 1 intervention - of which quadrivalent HPV vaccine is the first listed.
NCT01505049 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT01505049 about?
NCT01505049 is a clinical study titled "Immune Memory After Papillomavirus Vaccination". Vaccines for human papillomavirus (HPV) have been available in the United States since 2006. Early studies have shown a high rate of effectiveness of these vaccines, however it is not known how long this protection will last. The IMAP study will look at various parts of the immune system and potenti...
What is the current status of trial NCT01505049?
This trial is currently completed. The enrollment target is 203 participants. The study started on 2012-01. Estimated completion is 2015-01.
What conditions does trial NCT01505049 study?
This clinical trial studies the following conditions: Healthy Volunteers.
What interventions are being tested in trial NCT01505049?
The interventions under investigation include: quadrivalent HPV vaccine (DRUG).
Who is sponsoring clinical trial NCT01505049?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01505049 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adaptive Optics Retinal Imaging
RECRUITING
-
A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
RECRUITING · Phase 1
-
Acute Effects of High-intensity Interval Training With Mindfulness-based Recovery on Executive Function in Children
RECRUITING · NA
-
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
RECRUITING · Phase 1
-
Children s Growth and Behavior Study
RECRUITING
-
New Heart Imaging Techniques to Evaluate Possible Heart Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.